Wein Matthew sold MGX
March 5, 2026 · Form 4 insider transaction
Wein Matthew sold 482 shares of Metagenomi Therapeutics, Inc. at $1.60 per share, a transaction worth $771.20. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
482
Price
$1.60
Total value
$771.20
InsiderWein Matthew
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 5, 2026
Filing dateMarch 9, 2026
Shares owned after114,549
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.